Johnson & Johnson reported a quarterly earnings increase of 5% to $24.8 billion, driven by strong sales in its pharmaceutical division, while adjusting its full-year guidance upwards.
AI Assistant
JOHNSON & JOHNSON
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.